Krebs Biochemicals Financials

NSE: KREBSBIO | BSE: 524518

₹58.72

₹-2.75 (-4.47%)

As on 11-Sep-2026IST

Market cap

₹127 Cr

Revenue (TTM)

₹25 Cr

P/E Ratio

P/B Ratio

-0.8

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Operating Revenue	25.23	43.31	50.42	52.13	59.70	53.70
Total Income	27.41	44.02	50.87	52.75	60.86	54.32
Total Expenditure	27.77	58.34	59.15	67.91	93.70	71.28
EBITDA	-2.54	-15.03	-8.72	-15.78	-33.99	-17.58
Depreciation	6.41	6.69	6.77	6.56	6.30	5.12
EBIT	-8.95	-21.72	-15.49	-22.34	-40.29	-22.70
Interest	7.32	5.91	4.69	2.97	5.39	6.28
Other Income	2.17	0.71	0.45	0.62	1.16	0.62
Exceptional Items	--	--	--	--	--	--
Profit before Tax	-14.10	-26.92	-19.73	-24.69	-44.53	-28.36
Provision for Tax	--	0.02	--	--	--	--
Profit after Tax	-14.10	-26.94	-19.73	-24.69	-44.53	-28.36

Liabilities (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Shareholder's Funds	-162.75	-146.24	-119.22	-99.46	-75.09	-42.73
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	212.94	211.75	235.56	225.34	186.83	153.76
Current Liabilities	113.07	103.53	61.83	49.10	78.06	48.19
Total Liabilities	163.25	169.04	178.17	174.98	189.81	159.22

Assets (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Non-Current Assets	143.30	158.78	160.73	158.92	154.31	137.80
Current Assets	9.62	10.26	17.44	16.06	35.49	21.42
Total Assets	163.25	169.04	178.17	174.98	189.81	159.22
Total Debt*	--	212.21	193.68	183.37	143.10	111.14
Net Current Assets	-103.44	-93.27	-44.39	-33.04	-42.57	-26.77
Contingent Liabilities	--	9.26	9.26	5.63	5.55	5.49

Cashflow (₹ Cr)	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Cash From Operating Activities	--	-7.89	2.36	-24.71	-17.22	-14.57
Cash Flow from Investing Activities	--	-4.97	-7.82	-12.65	-22.90	-22.55
Cash from Financing Activities	--	12.86	5.50	37.34	39.51	37.66
Net Cash Inflow / Outflow	--	0.00	0.05	-0.01	-0.61	0.54

Financials Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Adjusted EPS (₹)	-6.54	-12.49	-9.15	-11.45	-20.65	-14.45
Cash EPS (₹)	-6.54	-9.39	-6.01	-8.41	-17.73	-11.84
Adjusted Book Value (₹)	-76.83	-67.83	-55.29	-46.13	-34.83	-23.91
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	--	-3.66	1.10	-11.46	-7.99	-7.43
Free Cash Flow per Share (₹)	--	-6.24	-5.64	-20.00	-22.92	-19.82

Profitability Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
ROCE (%)	--	-29.92	-18.99	-28.59	-57.38	-40.28
ROE (%)	--	--	--	--	--	--
ROA (%)	-8.48	-15.52	-11.17	-13.54	-25.51	-19.36
EBIT Margin (%)	-35.47	-50.14	-30.72	-42.85	-67.49	-42.27
Net Margin (%)	-51.43	-61.20	-38.78	-46.81	-73.16	-52.20
Cash Profit Margin (%)	0.00	-46.75	-25.71	-34.78	-64.03	-43.27

Growth Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Revenue Growth (%)	-29.72	-14.10	-3.29	-12.68	11.18	60.72
EBIT Growth (%)	58.40	-40.21	30.66	44.56	-77.49	2.30
Net Profit Growth (%)	47.97	-36.55	20.10	44.55	-57.01	1.78
EPS Growth (%)	47.97	-36.55	20.10	44.55	-42.89	9.89
Book Value Growth (%)	--	-22.67	-19.86	-32.45	-60.10	-43.66

Valuation Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Price / Earnings	-8.99	--	--	--	--	--
Price / Book Value	-0.76	-0.98	-1.10	-1.22	-4.12	-3.72
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-962.80	-24.86	-39.30	-20.11	-13.77	-16.79
Close Price (₹)	60.13	66.37	61.45	56.50	143.05	85.95
High Price (₹)	90.88	129.07	93.95	190.00	227.95	148.80
Low Price (₹)	38.33	60.00	50.65	50.65	82.50	60.10
Market Cap (₹ Cr)	126.71	144.00	131.56	121.60	309.18	174.33

Solvency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debt to Equity	-1.00	-1.45	-1.62	-1.84	-1.91	-2.37
Short term debt to equity ratio	--	-0.35	-0.08	-0.10	-0.13	-0.23
Current Ratio	0.09	0.10	0.28	0.33	0.45	0.44
Quick Ratio	0.03	0.04	0.12	0.08	0.13	0.10
Interest Coverage	-0.93	-3.55	-3.21	-7.30	-7.26	-3.52

Operating Efficiency Ratios	TTM	Mar-25	Mar-24	Mar-23	Mar-22	Mar-21
Debtors to sales (%)	0.02	0.12	3.77	1.01	1.47	0.56
Asset Turnover	0.15	0.25	0.29	0.29	0.34	0.37
Receivable days	--	8.23	8.79	4.91	3.60	1.71
Inventory Days	--	66.69	78.69	131.30	128.88	107.38
Payable days	--	1,219.44	948.90	378.02	263.51	305.42
Cash Conversion Cycle	--	-1,144.52	-861.42	-241.81	-131.03	-196.34

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)